MoneyWorks4Me

Venus Remedies informs about press release

20 Sep 2023 Evaluate

Venus Remedies has informed that it enclosed a press release being issued by the Company titled ‘Venus Remedies extends Its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1768.05
Dr. Reddys Labs. 1183.10
Cipla 1303.80
Lupin 1987.40
Zydus Lifesciences 1116.00
View more..